Compare BDSX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | ACR |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.0M | 141.1M |
| IPO Year | 2020 | N/A |
| Metric | BDSX | ACR |
|---|---|---|
| Price | $13.29 | $20.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $32.50 | $24.50 |
| AVG Volume (30 Days) | ★ 55.4K | 13.5K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,499,000.00 | N/A |
| Revenue This Year | $25.26 | N/A |
| Revenue Next Year | $19.15 | N/A |
| P/E Ratio | ★ N/A | $19.59 |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.25 | $16.51 |
| 52 Week High | $20.21 | $24.61 |
| Indicator | BDSX | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 72.53 |
| Support Level | $6.00 | $18.71 |
| Resistance Level | $16.26 | $21.27 |
| Average True Range (ATR) | 1.04 | 0.37 |
| MACD | -0.22 | 0.12 |
| Stochastic Oscillator | 26.76 | 96.35 |
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.